Wasman Jane 4
4 · SELLAS Life Sciences Group, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Wasman Jane
Director
Transactions
- Award
Common Stock
2022-01-31+1,900→ 1,900 total - Award
Stock Option (Right to Buy)
2022-01-31+7,125→ 7,125 totalExercise: $5.34Exp: 2032-01-31→ Common Stock (7,125 underlying)
Footnotes (2)
- [F1]The Reporting Person received an award of 1,900 restricted stock units on January 31, 2022, which shall vest in full on December 1, 2022, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
- [F2]The shares subject to the option will fully vest on the earlier of (x) January 31, 2023 (the first anniversary of the date of grant) or (y) the business day prior to the 2023 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.